Loading insider details...
Beta
Latest Form 4 (Jun 29, 2026): Grant/Award of 93,000 CLDX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 93,000 | n/a |
| Dec 8, 2025 | Celldex Therapeutics, Inc. (CLDX) | Sale | 4,166 | $121.2K |
| Aug 15, 2025 | Celldex Therapeutics, Inc. (CLDX) | Sale | 341 | $8.2K |
| Jun 9, 2025 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 75,000 | n/a |
| Jun 17, 2024 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 75,000 | n/a |
| Jun 7, 2024 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 9,540 | $99.0K |
| Jun 5, 2024 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 8,006 | $83.1K |
| Feb 15, 2024 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 4,166 | $37.6K |
| Jun 20, 2023 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 74,000 | n/a |
| Jun 17, 2022 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 73,000 | n/a |